Merve Ozkaya

Merve Ozkaya

Auto-generated profile, based on publicly available information

Merve Ozkaya

Institute of Health Sciences, Department of Nutrition and Dietetics, Ankara University, Ankara, Türkiye

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2026 in Euchembioj Reviews
Verified
Journal Article
Open access
GMGulsen Meral
Gulsen Meral
EAElif Sibel Aslan
Elif Sibel Aslan
NBNeval Burkay
Neval Burkay
MOMerve Ozkaya
Merve Ozkaya
EAESMA GÖKÇEN ALPER ACAR
ESMA GÖKÇEN ALPER ACAR
The worldwide prevalence of all cancer types continues to rise. In this context, the psychological burden of cancer—particularly anxiety and depression—has emerged as a critical yet frequently overlooked component of comprehensive oncological care. In addition to clinical and psychosocial factors, growing evidence suggests that epigenetic mechanisms significantly influence both cancer biology and mental health, indicating that gene-environment interactions may affect psychological vulnerability in oncology contexts. Nutrigenetics-based epigenetic approaches enable personalized dietary and nutraceutical interventions based on individual genetic variability. Green tea catechins and curcumin are widely used bioactive compounds due to their epigenetic and anticancer potential. However, by altering the activity of catechol-O-methyltransferase (COMT) and monoamine oxidase (MAO), important enzymes that degrade dopamine, norepinephrine, and serotonin, these substances have an impact on monoaminergic neurotransmission. Functional polymorphisms in the COMT and MAO genes may lead to substantial interindividual differences in mood regulation, stress responsiveness, and anxiety susceptibility. This review addresses molecular, clinical, and psycho-oncological aspects of the effects of green tea and curcumin on COMT and MAO pathways within a nutrigenetics-based epigenetic nutrition framework. The findings emphasize that the potential clinical benefits of epigenetically active nutraceuticals should be evaluated through a genotype-guided, individualized, and balanced approach.